|
|
||||||||
Instituto de Fermentaciones Industriales (CSIC), Juan de la Cierva 3, 28006 Madrid, Spain
Corresponding author: I. Recio; e-mail: recio{at}ifi.csic.es.
In this study, a potent angiotensin-converting enzyme (ACE)-inhibitory activity was found in a commercial kefir made from caprine milk. The low molecular mass peptides released from caseins during fermentation were mainly responsible for this activity. Sixteen peptides were identified by HPLC-tandem mass spectrometry. Two of these peptides, with sequences PYVRYL and LVYPFTGPIPN, showed potent ACE-inhibitory properties. The impact of gastrointestinal digestion on ACE-inhibitory activity of kefir peptides was also evaluated. Some of these peptides were resistant to the incubation with pepsin followed by hydrolysis with Corolase PP. The ACE-inhibitory activity after simulated digestion was similar to or slightly lower than unhydrolyzed peptides, except for peptide ß-casein f(47-52) (DKIHPF), which exhibited an activity 8 times greater after hydrolysis.
Key Words: angiotensin-converting enzyme-inhibitory activity caprine kefir simulated gastrointestinal digestion mass spectrometry
Abbreviation key: ACE = angiotensin-converting enzyme, IC50 = protein concentration needed to inhibit the original ACE activity by 50%, MS/MS = tandem mass spectrometry, RP-HPLC = reverse phase-HPLC, WSE = water-soluble extract
This article has been cited by other articles:
![]() |
A. Quiros, M. Ramos, B. Muguerza, M. A. Delgado, P. J. Martin-Alvarez, A. Aleixandre, and I. Recio Determination of the Antihypertensive Peptide LHLPLP in Fermented Milk by High-Performance Liquid Chromatography-Mass Spectrometry J Dairy Sci, December 1, 2006; 89(12): 4527 - 4535. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |